BioFocus Leads Compound Library Market with Innovative Business Model
News Apr 15, 2011
BioFocus has announced that it has established an innovative and unique model for the sale of its SoftFocus compound libraries. Going forward, BioFocus will provide a limited number of clients with SoftFocus libraries on a subscription basis only. These libraries are designed to target protein families of particular interest to the subscribers.
This shared exclusivity model will allow clients access to high value, novel compounds with limited competition on derived intellectual property.
“Our SoftFocus libraries have enjoyed a decade of success”, said Richard Gordon, Senior Director Sales and Marketing, BioFocus. “The introduction of this shared exclusivity model is a consequence of the success that the libraries have yielded for our clients. Our clients want a better position on IP generated from screening the libraries and we have adapted our model to accommodate their needs. This is a true testament to the value that our clients see in the SoftFocus brand.”
BioFocus will continue to provide support to customers of the existing SoftFocus non-exclusive libraries through the open access chemical structure search engine, eMolecules, and BioFocus’ improved resynthesis, scaffold and protocol program. The eMolecules platform allows users to search structural information and order pre-2011 SoftFocus compounds online.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug CandidateNews
Researchers have discovered that synthetic APC-mimicking small molecules called “parmodulins” provide anti-inflammatory and anti-thrombotic protection to endothelial cells on par with APC’s without interfering with normal blood clotting and coagulation, making them attractive new drug candidates.READ MORE